Hypoxia promotes liver stage malaria infection in primary human hepatocytes in vitro
Name
Ng-2013-Hypoxia promotes liv.pdf
Size
4.69 MB
Format
Adobe PDF
Checksum (MD5)
a9ef136e6141b91612c16aeb36a4f3f2
Author(s) • • • • • •
Ng, Shengyong
March-Riera, Sandra
Galstian, Ani
Hanson, Kirsten
Carvalho, Tania
Mota, Maria M.
Bhatia, Sangeeta N
Date Issued
November 2013
Journal
Disease Models & Mechanisms
Publisher
Company of Biologists
Citation
Ng, S., S. March, A. Galstian, K. Hanson, T. Carvalho, M. M. Mota, and S. N. Bhatia. “Hypoxia promotes liver stage malaria infection in primary human hepatocytes in vitro.” Disease Models & Mechanisms (November 28, 2013).
Version
Final published version
Abstract
Homeostasis of mammalian cell function strictly depends on balancing oxygen exposure to maintain energy metabolism without producing excessive reactive oxygen species. In vivo, cells in different tissues are exposed to a wide range of oxygen concentrations, and yet in vitro models almost exclusively expose cultured cells to higher, atmospheric oxygen levels. Existing models of liver stage malaria that utilize primary human hepatocytes typically exhibit low in vitro infection efficiencies, possibly due to missing microenvironmental support signals. One cue that may influence the infection capacity of cultured human hepatocytes is the dissolved oxygen concentration. We developed a microscale human liver platform comprised of precisely patterned primary human hepatocytes and nonparenchymal cells (MPCC) to model liver stage malaria, but the oxygen concentrations are typically higher in the in vitro liver platform than anywhere along the hepatic sinusoid. Indeed, we observed that liver stage Plasmodium parasite development in vivo correlates with hepatic sinusoidal oxygen gradients. Therefore, we hypothesized that in vitro liver stage malaria infection efficiencies may improve under hypoxia. Using the infection of MPCCs with P. berghei or P. yoelii as a model, we observed that ambient hypoxia resulted in increased survival of exo-erythrocytic forms (EEFs) in hepatocytes, and improved parasite development in a subset of surviving EEFs, based on EEF size. Further, the effective cell surface oxygen tensions (pO2) experienced by the hepatocytes, as predicted by a mathematical model, were systematically perturbed by varying culture parameters like hepatocyte density and media height, uncovering an optimal cell surface pO2 to maximize the number of mature EEFs. Initial mechanistic experiments reveal that treatment of primary human hepatocytes with the hypoxia mimetic, cobalt (II) chloride, as well as a HIF-1α activator, dimethyloxalylglycine, also enhance P. berghei infection, suggesting that the effect of hypoxia on infection is mediated in part by host-dependent HIF-1α mechanisms.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1242/dmm.013490